ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma
Article in Pathology - Research and Practice (March 2024)
The most recent citing publications are shown below. View all 166 publications that cite this research output on Dimensions.
Article in Pathology - Research and Practice (March 2024)
Article in SAR and QSAR in Environmental Research (February 2024)
Book chapter (January 2024)